Gilead Is Persona Non Grata
November 01, 2017 at 12:19 PM EDT
GILD's HCV revenue fell 28% Q/Q. Additional competition might have hastened its demise. Total revenue was off 9%. Yescarta is exciting but it will not be able to replace the HCV run-off and it will not kick in until 2018.
